Skip to main content
AEZS logo

Aeterna Zentaris Inc. (AEZS) Stock Analysis

DELISTED

What happened to Aeterna Zentaris Inc. (AEZS) stock?

Aeterna Zentaris Inc. (AEZS) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $17.5M| Vol: 7.5K| 52-wk range: $0.15 – $9.32

Market cap $17.5M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Aeterna Zentaris Inc. (AEZS). Aeterna Zentaris Inc. is a specialty biopharmaceutical company focused on developing and commercializing therapeutics and diagnostic tests.

Last analyzed: Jun 15, 2026
Aeterna Zentaris Inc. is a specialty biopharmaceutical company focused on developing and commercializing therapeutics and diagnostic tests. Its primary product, Macrilen (macimorelin), addresses adult and childhood-onset growth hormone deficiency, alongside a pipeline of licensed assets targeting infectious diseases, neurological disorders, and rare endocrine conditions.

Dated analysis: the newest financial statements on file are 31 months old (Mar 1, 2024), so the figures and score below describe that period, not today.

Aeterna Zentaris Inc. (AEZS) Healthcare & Pipeline Overview

Employees12
Model self-rating on this text: 68% (not a measure of the evidence) Updated: Jun 15, 2026

More about this archive record

Can I still buy AEZS shares?

No. AEZS stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for AEZS elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before AEZS stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Aeterna Zentaris Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.